Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 6
2005 3
2006 4
2007 8
2008 4
2009 12
2010 8
2011 5
2012 8
2013 10
2014 11
2015 8
2016 8
2017 4
2018 3
2019 4
2020 8
2021 5
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Development of an inactivated vaccine candidate for SARS-CoV-2.
Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C. Gao Q, et al. Among authors: yin w. Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6. Science. 2020. PMID: 32376603 Free PMC article.
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents.
Cao Y, Jian F, Zhang Z, Yisimayi A, Hao X, Bao L, Yuan F, Yu Y, Du S, Wang J, Xiao T, Song W, Zhang Y, Liu P, An R, Wang P, Wang Y, Yang S, Niu X, Zhang Y, Gu Q, Shao F, Hu Y, Yin W, Zheng A, Wang Y, Qin C, Jin R, Xiao J, Xie XS. Cao Y, et al. Among authors: yin w. Cell Rep. 2022 Dec 20;41(12):111845. doi: 10.1016/j.celrep.2022.111845. Epub 2022 Dec 1. Cell Rep. 2022. PMID: 36493787 Free PMC article.
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Zhang Y, et al. Among authors: yin w. Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17. Lancet Infect Dis. 2021. PMID: 33217362 Free PMC article. Clinical Trial.
A novel peptide adropin in cardiovascular diseases.
Li L, Xie W, Zheng XL, Yin WD, Tang CK. Li L, et al. Clin Chim Acta. 2016 Jan 30;453:107-13. doi: 10.1016/j.cca.2015.12.010. Epub 2015 Dec 10. Clin Chim Acta. 2016. PMID: 26683354 Review.
Lipoprotein lipase: from gene to atherosclerosis.
Li Y, He PP, Zhang DW, Zheng XL, Cayabyab FS, Yin WD, Tang CK. Li Y, et al. Atherosclerosis. 2014 Dec;237(2):597-608. doi: 10.1016/j.atherosclerosis.2014.10.016. Epub 2014 Oct 18. Atherosclerosis. 2014. PMID: 25463094 Review.
Lipoprotein lipase activator NO-1886.
Yin W, Tsutsumi K. Yin W, et al. Cardiovasc Drug Rev. 2003 Summer;21(2):133-42. doi: 10.1111/j.1527-3466.2003.tb00111.x. Cardiovasc Drug Rev. 2003. PMID: 12847564 Review.
118 results